The Parenteral Drug Association released, Technical Report No. 68: Risk-Based Approach for Prevention and Management of Drug Shortages(TR-68) to the public for free in an effort to reduce potential drug shortages caused by manufacturing quality issues.
PDA has also made TR-68 available for all health authorities to post on their websites and will make electronic editable versions of the templates available to the industry. PDA will initiate training to enable quick industry adoption of the tools and templates
TR-68 is the first ever structured, product-based approach for proactive identification and management of potential drug shortages caused by manufacturing quality issues. It outlines a risk-based approach for identifying issues that could lead to potential drug shortages. The Report provides practical guidance and tools for implementation of a proactive plan for avoiding drug shortages.
“It is our hope that all of industry will be able to immediately implement the methods, tools, and templates presented in the Technical Report to prevent these shortages,” said PDA President Richard Johnson. “PDA is committed to continuing work on additional solutions for addressing drug shortages to achieve the goal of better serving patients.”
The full report is available here.
